Pharmacological possibilities for protection against myocardial reperfusion injury.

@article{Wang2002PharmacologicalPF,
  title={Pharmacological possibilities for protection against myocardial reperfusion injury.},
  author={Qing-Dong Wang and John Pernow and Per-Ove Sj{\"o}quist and Lars Ryd{\'e}n},
  journal={Cardiovascular research},
  year={2002},
  volume={55 1},
  pages={25-37}
}
Reperfusion through thrombolysis or percutananeous coronary angioplasty is standard treatment in impending acute myocardial infarction. Although restoration of blood flow to the jeopardised myocardial area is a perquisite for myocardial salvage, reperfusion itself may lead to accelerated and additional myocardial injury beyond that generated by ischemia alone. This is referred to as the "reperfusion injury". Since the reperfusion injury is initiated by the treatment of myocardial infarction, it… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 62 extracted citations

Ginsenoside Rg1 Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury via Activation of Nrf2/HO-1 Signaling and Inhibition of JNK.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology • 2017

Sending and Receiving Hedgehog Signals.

Annual review of cell and developmental biology • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…